Product image of Glycopyrronium Bromide Accord Healthcare (Glycopyrronium Bromide) supplied by GNH India

Glycopyrronium Bromide Accord Healthcare

Active Ingredient:
Glycopyrronium Bromide
Origin:
EU

Glycopyrronium Bromide Accord Healthcare (Glycopyrronium Bromide)

Glycopyrronium Bromide Accord Healthcare is a prescription medication that contains the active ingredient glycopyrronium bromide. It is supplied in an injectable form for intramuscular or intravenous administration, with the specific strength provided by Accord Healthcare for use in the European market. The product belongs to the anticholinergic (muscarinic antagonist) class and is used as a bronchodilator in respiratory therapy.

Manufacturer / TM Owner

Accord Healthcare Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glycopyrronium Bromide is indicated for the management of chronic obstructive pulmonary disease (COPD) and related airway obstruction. It is employed as a maintenance therapy to improve breathing and reduce symptoms.

  • Long‑term treatment of COPD to decrease bronchospasm
  • Adjunct therapy for patients with persistent airflow limitation
  • Helps improve lung function and exercise tolerance
  • May be used when other bronchodilators are insufficient
  • Supports reduction of mucus secretion in the airways

Side Effects

Side effects of glycopyrronium bromide vary in frequency and severity. Common reactions are usually mild, while serious events are less frequent but require medical attention.

Common

  • Dry mouth
  • Constipation
  • Urinary retention
  • Blurred vision
  • Tachycardia
  • Headache

Serious

  • Severe allergic reaction (rash, swelling, difficulty breathing)
  • Acute angle‑closure glaucoma
  • Cardiac arrhythmias
  • Paradoxical bronchospasm
  • Persistent urinary retention requiring intervention

Precautions & Warnings

Before using glycopyrronium bromide, certain health considerations should be reviewed to ensure safe use.

  • Assess for a history of urinary retention, prostate enlargement, or bladder outlet obstruction
  • Use cautiously in patients with narrow‑angle glaucoma or other ocular disorders
  • Monitor cardiovascular status in individuals with arrhythmias or heart disease
  • Consider dose adjustment in hepatic impairment
  • Evaluate risks versus benefits in elderly patients
  • Pregnancy and lactation safety data are limited; discuss with a healthcare professional

Avoid Interactions

Glycopyrronium bromide may interact with other medicines, affecting its efficacy or safety profile.

Avoid

  • Concurrent use of other anticholinergic agents that may increase anticholinergic burden
  • Drugs known to prolong the QT interval when combined with glycopyrronium bromide

Use with caution

  • Beta‑agonists or other bronchodilators, as additive bronchodilation may occur
  • Cholinesterase inhibitors used for myasthenia gravis or Alzheimer’s disease
  • Medications that affect urinary retention, such as antihistamines or tricyclic antidepressants
  • Cardiovascular drugs that influence heart rate or rhythm

Frequently Asked Questions

Glycopyrronium bromide works by competitively blocking muscarinic acetylcholine receptors in the airway smooth muscle, leading to relaxation of the bronchi and reduced mucus secretion.

The medication is supplied as an injectable solution and can be given either intramuscularly or intravenously under the supervision of a healthcare professional.

No, glycopyrronium bromide is intended for maintenance therapy of COPD and is not typically used as a short‑acting rescue medication.

While it is primarily approved for COPD, a healthcare provider may consider off‑label use in asthma after evaluating the individual’s clinical situation.

Common side effects include dry mouth, constipation, urinary retention, blurred vision, tachycardia, and headache.

Medical attention is needed if the patient experiences signs of a severe allergic reaction, acute angle‑closure glaucoma, significant arrhythmias, or persistent urinary retention.

Safety data for use during pregnancy are limited; the medication should only be used if the potential benefit justifies the potential risk to the fetus.

Elderly patients may be more susceptible to anticholinergic side effects such as urinary retention and constipation, so careful monitoring is advised.

Yes, using glycopyrronium bromide together with beta‑agonist bronchodilators may increase bronchodilation; clinicians often monitor lung function when both are prescribed.

Store the injectable solution at controlled room temperature, away from light and moisture, and keep it out of reach of children.

The ATC classification for glycopyrronium bromide is R03BB02, indicating it is a bronchodilator in the anticholinergic subgroup.

Glycopyrronium bromide is not classified as a controlled substance; it is available by prescription only.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glycopyrronium Bromide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT